SYNERGISTIC INHIBITION OF ERBB2/ERBB3 SIGNAL PATHWAYS IN THE TREATMENT OF CANCER

• 收藏
• 分享

专利权人:

发明人:

Matthew K. Robinson,Smitha Reddy

申请号：

US14089851

公开号：

US20140105919A1

申请日:

2013.11.26

申请国别(地区):

US

年份:

2014

代理人:

摘要：

Methods for treating tumors comprising cells overexpressing ErbB2 or ErbB3 are provided, and comprise inhibiting the biologic activity of one or more of ErbB2 and ErbB3 in the cells and inhibiting the expression or the biologic activity of a constituent of a signal pathway connected with ErbB2 or ErbB3 signaling.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/